Inamed fat products buck thin sales trend:
This article was originally published in Clinica
Executive Summary
Surgical and medical device company Inamed said that its second-quarter sales were down by 4.5%, due to lower breast implant prices and poor sales of collagen products in Europe. The company blamed mad cow disease for falling collagen sales, but said that obesity products were strong in "the first half of the second quarter".
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.